Erlotinib in the Treatment of Leptomeningeal Metastases: A Case Study
This article breaks down how erlotinib, a targeted therapy for EGFR-positive tumors, can make a real difference in treating leptomeningeal metastases—a tough complication in certain cancers. It walks through a detailed case study to show what happens in the real world, not just in textbooks. You’ll get facts on how the drug works, what to expect with treatment, side effects to watch for, and practical tips for patients and families. Evidence from recent studies helps ground the article in what’s known so far. If you’re looking for direct, useful info on erlotinib for these tricky brain and spinal cord metastases, this one’s for you.
Read More